Clinical Case Series - FL - Question 3
{"name":"Clinical Case Series - FL - Question 3", "url":"https://www.poll-maker.com/QWNHLFV3B","txt":"Administration of tazemetostat with strong or moderate CYP3A inhibitors may increase the frequency or severity of adverse reactions. Who in your clinic is most frequently responsible for medication reconciliation with oral oncolytics?","img":"https://www.poll-maker.com/3012/images/ogquiz.png"}